tamoxifen
Because of the partial estrogenic activity of       tamoxifen in the endometrium, its clinical use is associated with uterine       hypertrophy and an increased risk of endometrial cancer.
Because of the partial estrogenic activity of        @SUBJECT$  in the endometrium, its clinical use is associated with uterine       hypertrophy and an increased  @PREDICAT$  of  @OBJECT$ .